These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Clinical aspects of Rh incompatibility. I. Transient disorders of erythropoiesis as a result of persistent Rh-antibodies after exchange transfusion]. Reitzig C; Gmyrek D; Syllm-Rapoport I Dtsch Gesundheitsw; 1971 Mar; 26(11):497-503. PubMed ID: 4995286 [No Abstract] [Full Text] [Related]
25. [Evaluation of psychosomatic development and selected laboratory parameters of infants treated by exchange transfusion for serologic incompatibility]. Słowik J; Balcar-Boroń A; Swincow G Acta Haematol Pol; 1988; 19(3-4):188-92. PubMed ID: 3150893 [No Abstract] [Full Text] [Related]
26. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Osborn LM; Lenarsky C; Oakes RC; Reiff MI Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318 [TBL] [Abstract][Full Text] [Related]
27. [Blood group determination and compatability testing]. Metaxas M Schweiz Med Wochenschr; 1971 Oct; 101(42):1493-5. PubMed ID: 5004033 [No Abstract] [Full Text] [Related]
28. Prevention of maternal-fetal blood group incompatibility with traditional Chinese herbal medicine. Bian X; Xu Y; Zhu L; Gao P; Liu X; Liu S; Qian M; Gai M; Yang J; Wu Y Chin Med J (Engl); 1998 Jul; 111(7):585-7. PubMed ID: 11245041 [TBL] [Abstract][Full Text] [Related]
29. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Lozano M; Cid J Transfus Med Rev; 2003 Jan; 17(1):57-68. PubMed ID: 12522772 [TBL] [Abstract][Full Text] [Related]
30. [Current aspects of hepatic oma therapy]. San Juan F Hospital (Rio J); 1969 Nov; 76(5):1539-50. PubMed ID: 4907032 [No Abstract] [Full Text] [Related]
31. [Therapeutic measures after transfusion of incompatible blood]. Gaerisch F; Usbeck W; Dieterich F Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(2):178-89. PubMed ID: 4167549 [No Abstract] [Full Text] [Related]
32. [A puerperal woman received massive ABO-incompatible blood transfusion: a case report rescued by exchange transfusion therapy]. Fujiki Y; Okane M; Asaka M; Nabeshima Y; Saito M; Kubo T Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):533-6. PubMed ID: 8754396 [No Abstract] [Full Text] [Related]
33. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure. Ceccon ME; Diniz EM; Ramos JL; Vaz FA Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577 [TBL] [Abstract][Full Text] [Related]
35. [Hemolytic disease of the newborn as a result of ABO incompatibility and unusual fetogenic sensitizations]. DAMEROW R Ergeb Inn Med Kinderheilkd; 1963; 19():132-205. PubMed ID: 14024821 [No Abstract] [Full Text] [Related]
36. [Errors and hazards of blood transfusion and their prevention]. Güthenke H Z Arztl Fortbild (Jena); 1974 Jul; 68(14):695-8. PubMed ID: 4216181 [No Abstract] [Full Text] [Related]
37. [Anemia after exchange transfusion for jaundice without blood incompatibility in premature infants]. Boissière H; Cagnat R; Hermet B Ann Pediatr (Paris); 1969; 16(8):518-24. PubMed ID: 4981660 [No Abstract] [Full Text] [Related]
38. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)]. Di Piero G; Mencarini L; Ottaviano S; Lapi AS Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851 [No Abstract] [Full Text] [Related]
39. [Materno-fetal incompatibility in the ABO system as a factor of protection against hemolytic disease caused by Rh incompatibility]. Mollica F Minerva Pediatr; 1967 Mar; 19(13):610-1. PubMed ID: 4963996 [No Abstract] [Full Text] [Related]
40. [Brain damage from blood group incompatibility]. Rett A Wien Med Wochenschr; 1970 Apr; 120(15):251-3. PubMed ID: 4994455 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]